Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Nederlands Tijdschrift Voor Geneeskunde
|
January 31, 2009
[From gene to drug: recent developments in medicinal chemistry]
I J P de Esch, R Leurs
Mini Reviews in Medicinal Chemistry
|
November 17, 2004
Histamine H3 receptor agonists
I J P De Esch, K J Belzar
Plos One
|
March 30, 2023
Micro-foundations of dynamic capabilities to facilitate university technology transfer
Zhongxuan Ma, K D Augustijn, I J P De Esch, et al.
British Journal of Pharmacology
|
May 30, 2013
A structural chemogenomics analysis of aminergic GPCRs: lessons for histamine receptor ligand design
A J Kooistra, S Kuhne, I J P de Esch, et al.
Ernst Schering Foundation Symposium Proceedings
|
August 21, 2007
Virus-encoded G-protein-coupled receptors: constitutively active (dys)regulators of cell function and their potential as drug target
H F Vischer, J W Hulshof, I J P de Esch, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 7, 2012
VUF10166, a novel compound with differing activities at 5-HT₃A and 5-HT₃AB receptors
A J Thompson, M H P Verheij, I J P de Esch, et al.
Drug Discovery Today. Technologies
|
July 4, 2014
C(X)CR in silico: Computer-aided prediction of chemokine receptor-ligand interactions
L Roumen, D J Scholten, P de Kruijf, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 4, 2007
Antinociceptive activity of furan-containing congeners of improgan and ranitidine
L B Hough, W M P B Menge, A C van de Stolpe, et al.
Drug Discovery Today. Technologies
|
December 13, 2021
Career development in fragment-based drug discovery
A K S Romasanta, P C van der Sijde, M J Smit, et al.
British Journal of Pharmacology
|
September 3, 2011
Pharmacological characterization of a small-molecule agonist for the chemokine receptor CXCR3
D J Scholten, M Canals, M Wijtmans, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Nederlands Tijdschrift Voor Geneeskunde
|
January 31, 2009
[From gene to drug: recent developments in medicinal chemistry]
I J P de Esch, R Leurs
Mini Reviews in Medicinal Chemistry
|
November 17, 2004
Histamine H3 receptor agonists
I J P De Esch, K J Belzar
Plos One
|
March 30, 2023
Micro-foundations of dynamic capabilities to facilitate university technology transfer
Zhongxuan Ma, K D Augustijn, I J P De Esch, et al.
British Journal of Pharmacology
|
May 30, 2013
A structural chemogenomics analysis of aminergic GPCRs: lessons for histamine receptor ligand design
A J Kooistra, S Kuhne, I J P de Esch, et al.
Ernst Schering Foundation Symposium Proceedings
|
August 21, 2007
Virus-encoded G-protein-coupled receptors: constitutively active (dys)regulators of cell function and their potential as drug target
H F Vischer, J W Hulshof, I J P de Esch, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 7, 2012
VUF10166, a novel compound with differing activities at 5-HT₃A and 5-HT₃AB receptors
A J Thompson, M H P Verheij, I J P de Esch, et al.
Drug Discovery Today. Technologies
|
July 4, 2014
C(X)CR in silico: Computer-aided prediction of chemokine receptor-ligand interactions
L Roumen, D J Scholten, P de Kruijf, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 4, 2007
Antinociceptive activity of furan-containing congeners of improgan and ranitidine
L B Hough, W M P B Menge, A C van de Stolpe, et al.
Drug Discovery Today. Technologies
|
December 13, 2021
Career development in fragment-based drug discovery
A K S Romasanta, P C van der Sijde, M J Smit, et al.
British Journal of Pharmacology
|
September 3, 2011
Pharmacological characterization of a small-molecule agonist for the chemokine receptor CXCR3
D J Scholten, M Canals, M Wijtmans, et al.
Page
of 2